Home › Funds › Bellevue Group AG › DARE
Bellevue Group AG position in DARE
YARROW BIOSCIENCE INC · Health Care
Bellevue Group AG reported holding 1,000,000 shares of DARE (YARROW BIOSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$22.5M, representing 0.47% of its reported portfolio and ranking #49 among its reported holdings. Bellevue Group AG first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's DARE position evolved
Bellevue Group AG first disclosed a stake in DARE in Q3 2026 at 1,000,000 shares (US$22.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.00M | $22.52M | New |
About DARE and 13F data
DARE (YARROW BIOSCIENCE INC) is a Health Care company. 56 other funds we track also report a position in DARE — the largest reported positions include Logos Global Management LP (US$23.1M), PERCEPTIVE ADVISORS LLC (US$18.3M), Spruce Street Capital LP (US$13.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DARE
- Logos Global Management LP 1.03M sh · $23.11M · Q3 2026
- PERCEPTIVE ADVISORS LLC 813.10K sh · $18.31M · Q3 2026
- Spruce Street Capital LP 607.38K sh · $13.68M · Q3 2026
- venBio Partners LLC 554.77K sh · $12.49M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 301.92K sh · $6.80M · Q3 2026
- Squadron Capital Management LLC 225.00K sh · $5.07M · Q3 2026
- Monashee Investment Management LLC 40.00K sh · $900.80K · Q3 2026
- Lynx1 Capital Management LP 22.00K sh · $495.44K · Q3 2026
- KVP Capital Advisors, LP 10.01K sh · $225.45K · Q3 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held DARE?
Bellevue Group AG has disclosed DARE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Bellevue Group AG's current position in DARE?
As of Q3 2026, Bellevue Group AG holds 1.00M shares of DARE (YARROW BIOSCIENCE INC), valued at $22.52M, representing 0.47% of its reported portfolio and ranking #49.
Has Bellevue Group AG been buying or selling DARE?
In the latest 13F filing (Q3 2026), Bellevue Group AG newly opened its position in DARE.
Which other funds hold DARE?
Other major institutional holders of DARE include Logos Global Management LP, PERCEPTIVE ADVISORS LLC, Spruce Street Capital LP, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.